Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tight glucose control with insulin using the Leuven algorithm in adult critically ill patients
2018-000756-17Phase 3Active
- Sponsor
- KU Leuven
- Start
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of human insulin in Stress Hyperglycemia (SH) and hyperglycemia (2 arms), sponsored by KU Leuven. Primary endpoints: Incidence of new infections during ICU stay and Duration of ICU dependency. Started Mar 2018; status: active.
02
Drugs
human insulin
03
Conditions
Stress Hyperglycemia (SH)hyperglycemia
Beyond the preview
Go deeper on 2018-000756-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000756-17.